Suppr超能文献

多汗症:基于现代治疗方式的疾病病因、分类及管理

Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities.

作者信息

Kisielnicka Anna, Szczerkowska-Dobosz Aneta, Purzycka-Bohdan Dorota, Nowicki Roman J

机构信息

Department of Dermatology, Venereology and Allergology, Faculty of Medicine, Medical University of Gdansk, Gdansk, Poland.

出版信息

Postepy Dermatol Alergol. 2022 Apr;39(2):251-257. doi: 10.5114/ada.2022.115887. Epub 2022 May 9.

Abstract

Hyperhidrosis is a disorder of sweat glands characterized by overproduction of sweat, which is inadequate to the thermoregulatory needs of the body system. Owing to the heavy social and economic burden of the disproportionate perspiration, current treatment methods still do not seem to be sufficient enough to reach patients' expectations. Therefore, the researchers continue a robust pursuit of novel therapy modalities such as topical treatment methods, oral agents, minimally-invasive medical approach and surgical techniques. In this review article authors summarise the disease outline with the emphasis on the new era of hyperhidrosis treatment methods.

摘要

多汗症是一种汗腺紊乱疾病,其特征是出汗过多,而这与身体系统的体温调节需求不相称。由于这种过度出汗带来的沉重社会和经济负担,目前的治疗方法似乎仍不足以达到患者的期望。因此,研究人员继续大力探索新的治疗方式,如局部治疗方法、口服药物、微创医疗方法和手术技术。在这篇综述文章中,作者总结了该疾病的概况,并重点介绍了多汗症治疗方法的新时代。

相似文献

5
Surgical management of primary hyperhidrosis.原发性多汗症的外科治疗
Br J Surg. 1991 Mar;78(3):279-83. doi: 10.1002/bjs.1800780306.
6
Hyperhidrosis: A Review of Recent Advances in Treatment with Topical Anticholinergics.多汗症:外用抗胆碱能药物治疗的最新进展综述
Dermatol Ther (Heidelb). 2022 Dec;12(12):2705-2714. doi: 10.1007/s13555-022-00838-3. Epub 2022 Nov 3.
7
8
Topical glycopyrrolate for patients with facial hyperhidrosis.面部多汗症患者外用格隆溴铵
Br J Dermatol. 2008 May;158(5):1094-7. doi: 10.1111/j.1365-2133.2008.08476.x. Epub 2008 Feb 22.

引用本文的文献

4
Unilateral Sweating: A Case Study of Localized Unilateral Hyperhidrosis.单侧出汗:局限性单侧多汗症的病例研究
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2978-S2980. doi: 10.4103/jpbs.jpbs_125_24. Epub 2024 May 29.
7
Hyperhidrosis and Neurofibromatosis Type 1: A Case Report.多汗症与1型神经纤维瘤病:一例报告
Cureus. 2024 Jun 24;16(6):e63021. doi: 10.7759/cureus.63021. eCollection 2024 Jun.
9
Hyperhidrosis: assessment and management in general practice.多汗症:全科医疗中的评估与管理
Br J Gen Pract. 2024 Apr 25;74(742):236-238. doi: 10.3399/bjgp24X737361. Print 2024 May.

本文引用的文献

2
Ross Syndrome.罗斯综合征
Neuroophthalmology. 2019 Dec 12;44(3):201-203. doi: 10.1080/01658107.2019.1669184. eCollection 2020 Jun.
4
Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions.手掌多汗症的管理策略:挑战与解决方案
Clin Cosmet Investig Dermatol. 2019 Oct 4;12:733-744. doi: 10.2147/CCID.S210973. eCollection 2019.
6
Pharmacology, toxicology and clinical safety of glycopyrrolate.格隆溴铵的药理学、毒理学和临床安全性。
Toxicol Appl Pharmacol. 2019 May 1;370:154-169. doi: 10.1016/j.taap.2019.03.016. Epub 2019 Mar 21.
9
Hyperhidrosis: prevalence and impact on quality of life.多汗症:患病率及其对生活质量的影响。
J Bras Pneumol. 2018 Jul-Aug;44(4):292-298. doi: 10.1590/S1806-37562017000000379. Epub 2018 Jul 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验